patch_informationEarlier this month, Teva Pharmaceutical Industries, Ltd. announced it was voluntarily suspending sales, marketing, and distribution of ZECUITY® (sumatriptan iontophoretic transdermal system). Teva received reports of application site reactions described as burns and scars in patients treated with ZECUITY. The National Headache Foundation last wrote about ZECUITY in 2015 after it was announced that the patch would be available by prescription through special pharmacies. In 2016, the National Headache Foundation is encouraging all sufferers to rule their headaches. Hundreds gathered in Chicago to May 21, 2016 for The Purple Ball as we raised money to support education, research, and encourage headache sufferers everywhere to be engaged in the management...


About dehydration

To function correctly and remain healthy, our body requires the correct internal balance of water and electrolytes. Every day our body loses fluid and electrolytes via urine, sweat, saliva, and other bodily fluids. Usually, a normal, healthy diet will serve to replace lost electrolytes and fluid. Certain conditions such as vomiting and diarrhea, heavy sweating, or lack of food and fluid intake can lead to inadequate levels of fluid and electrolytes within our bodies. This is known as dehydration.

By Ryan J. Cady, MS; J. Kent Dexter, MD; Roger K. Cady, MD of The Headache Care Center in Springfield, Missouri In the annals of migraine, one of the most fascinating stories is how, in 1966, a physician named Robert Rabkin observed that the drug propranolol could prevent migraine. Dr. Rabkin was actually conducting a study using a beta-blocker (propranolol) to treat heart pain (angina) and fortuitously observed that one of his research subjects had a remarkable reduction in the frequency of his migraine attacks. A decade later, Drs. Seymour Diamond and John Graham presented their experience treating 86 migraine patients with daily propranolol to the Food and Drug Administration (FDA), and demonstrated that propranolol was indeed efficacious and safe for migraine prophylactic therapy. Subsequently, propranolol became the first FDA-approved medication for the prevention of migraine.

Iceberg Ad The National Headache Foundation has been supporting clinical and basic science research in headache and its causes for over 25 years. These grants have served as springboards to obtaining over $7 million in federal funding of headache-related research. Newer resources have facilitated the application process and the review process. Grants are now available, up to $100,000 per protocol, for research support. We are focusing the current campaign to protocols dealing with cluster headaches. This effort is supported by the Hope Schwab Fund in partnership with the National Headache Foundation.

Over the last couple of years the National Headache Foundation has developed a program to better help you—the headache and migraine sufferer. The Certificate of Added Qualification (CAQ) in Headache Medicine was reinstated to better set the standards for headache practice and assist those with headache in locating clinicians who could provide optimal headache-related health care.